AVROBIO, Inc. Gains 93.7%

Wed, Feb 08, 2023 at 07:05 PM

AVROBIO, Inc. (AVRO:NASDAQ) rocketted at $1.69, a gain of 93.7%. On Wed, Feb 08, 2023, AVRO:NASDAQ hit a New 2-Week High of $1.69. From Wed, Jan 25, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days

About AVROBIO, Inc. (AVRO:NASDAQ)

Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.

Top 10 Gainers:

Allied Healthcare Products, Inc. (AHPI:NASDAQ), 187.13%
AVROBIO, Inc. (AVRO:NASDAQ), 93.7%
Guardforce AI Co. Limited (GFAI:NASDAQ), 58.36%
Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 52.53%
PainReform Ltd. (PRFX:NASDAQ), 44.72%
Bluejay Diagnostics Inc. (BJDX:NASDAQ), 33.98%
Takung Art Co., Ltd. (TKAT:NYSEMKT), 29.14%
VIQ Solutions Inc. (VQS:NASDAQ), 28.9%
SoundHound AI Inc. (SOUN:NASDAQ), 28.61%
TH International Limited (THCH:NASDAQ), 26.19%